Biotech is Back to Work: JPM 2023 Week Wrap Up
LaVoie Health Science Blog
JANUARY 30, 2023
JP Morgan Week wrapped up earlier this month with a flurry of new data, partnerships, investor meetings, and pharmaceutical interest. While the overall economy is influencing the industry, a continued emphasis on value-based care will push the biotech sector through these uncertain times.
98 
Let's personalize your content